GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · Real-Time Price · USD
0.3125
-0.0464 (-12.93%)
At close: Apr 24, 2026, 4:00 PM EDT
0.3130
+0.0005 (0.16%)
After-hours: Apr 24, 2026, 7:46 PM EDT
GT Biopharma Market Cap
GT Biopharma has a market cap or net worth of $9.86 million as of April 24, 2026. Its market cap has increased by 101.24% in one year.
Market Cap
9.86M
Enterprise Value
3.05M
1-Year Change
101.24%
Ranking
Category
Stock Price
$0.31
Market Cap Chart
Since March 27, 2018, GT Biopharma's market cap has decreased from $83.20M to $9.86M, a decrease of -88.15%. That is a compound annual growth rate of -23.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 9.90M | 19.28% |
| Dec 31, 2025 | 8.30M | 22.06% |
| Dec 31, 2024 | 6.80M | -35.85% |
| Dec 29, 2023 | 10.60M | -63.19% |
| Dec 30, 2022 | 28.80M | -69.13% |
| Dec 31, 2021 | 93.30M | 181.02% |
| Dec 31, 2020 | 33.20M | 503.64% |
| Dec 31, 2019 | 5.50M | -83.13% |
| Dec 31, 2018 | 32.60M | -60.82% |
| Mar 27, 2018 | 83.20M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lunai Bioworks | 11.25M |
| Imunon | 10.94M |
| Aprea Therapeutics | 10.65M |
| Kiora Pharmaceuticals | 10.31M |
| Quoin Pharmaceuticals | 10.28M |
| Enveric Biosciences | 10.01M |
| Evogene | 9.92M |
| Genprex | 9.39M |